Back to search

Article

Novel Gene Signatures Predictive of Patient Recurrence-free Survival in HR+HER2- Breast Cancer

2024-02-09

Abstract excerpt

<h4>Purpose: </h4> Predicting relapse-free survival (RFS) and understanding the molecular characteristics of endocrine therapy resistance are crucial for determining the treatment decision-making process in HR+/HER2- breast cancer patients. To address this, the main purpose of this study was to develop a signature to predict RFS in HR+/HER2- breast cancer patients Methods We analyzed transcriptome and clinical da...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cd750051-e624-5af7-9bad-ca53b9a01f7b
DOI
10.21203/rs.3.rs-3930524/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Novel Gene Signatures Predictive of Patient Recurrence-free Survival in HR+HER2- Breast CancerDOI 10.21203/rs.3.rs-3930524/v1
A novel twelve-gene signature to evaluate neoadjuvant chemotherapy response and predict prognosis in breast cancerSemantic proximity
A gene expression signature in HER2+ breast cancer patients related to neoadjuvant chemotherapy resistance, overall survival, and disease-free survivalSemantic proximity
A novel gene signature to predict response to neoadjuvant chemotherapy and endocrine treatment in estrogen receptor-positive breast cancer patientsSemantic proximity
Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast CancerSemantic proximity
Prognostic Predictors Do Not Equate to Predictors of Chemotherapy Benefit in HR-Positive, HER2-Negative Breast Cancer: A Population-Based StudySemantic proximity
Genomic hallmarks of endocrine therapy resistance in ER/PR+HER2- breast tumoursSemantic proximity
Gene expression associated with endocrine therapy resistance in estrogen receptor-positive breast cancerSemantic proximity
ENDORSE: a prognostic model for endocrine therapy response in advanced estrogen-receptor positive breast cancersSemantic proximity
PTCH1 and CTNNB1 emerge as pivotal predictors of resistance to neoadjuvant chemotherapy in ER+/HER2- breast cancerSemantic proximity
Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancerSemantic proximity
Determining the Factors Predicting the Response to Anti-HER2 Therapy in HER2-Positive Breast Cancer PatientsSemantic proximity
Network-based Approach to Identify Prognosis-related Genes in Tamoxifen-treated Patients With Estrogen Receptor-positive Breast CancerSemantic proximity
Select a neighboring publication to make it the new centre.